372 related articles for article (PubMed ID: 27995483)
1. Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.
Consolino L; Longo DL; Sciortino M; Dastrù W; Cabodi S; Giovenzana GB; Aime S
Gastric Cancer; 2017 Jul; 20(4):629-639. PubMed ID: 27995483
[TBL] [Abstract][Full Text] [Related]
2. microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.
Fan R; Zhong J; Zheng S; Wang Z; Xu Y; Li S; Zhou J; Yuan F
Clin Exp Med; 2015 May; 15(2):137-44. PubMed ID: 24706111
[TBL] [Abstract][Full Text] [Related]
3. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.
Bauer S; Duensing A; Demetri GD; Fletcher JA
Oncogene; 2007 Nov; 26(54):7560-8. PubMed ID: 17546049
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and pathologic analysis of imatinib-resistant gastrointestinal stromal tumor xenografts].
Zheng S; Wang XJ; Jia J; Pan YL; Tao DY; Lu HS; Huang KE
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):176-80. PubMed ID: 22800481
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro and in vivo evaluation of
Prause M; Niedermoser S; Wängler C; Decristoforo C; Seibold U; Riester S; Taguchi T; Schirrmacher R; Fricker G; Wängler B
Nucl Med Biol; 2018 Feb; 57():1-11. PubMed ID: 29175467
[TBL] [Abstract][Full Text] [Related]
6. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
7. Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.
Desai J; Shankar S; Heinrich MC; Fletcher JA; Fletcher CD; Manola J; Morgan JA; Corless CL; George S; Tuncali K; Silverman SG; Van den Abbeele AD; van Sonnenberg E; Demetri GD
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5398-405. PubMed ID: 17875769
[TBL] [Abstract][Full Text] [Related]
8. In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
Huuse EM; Moestue SA; Lindholm EM; Bathen TF; Nalwoga H; Krüger K; Bofin A; Maelandsmo GM; Akslen LA; Engebraaten O; Gribbestad IS
J Magn Reson Imaging; 2012 May; 35(5):1098-107. PubMed ID: 22170753
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
[TBL] [Abstract][Full Text] [Related]
10. Inhibition effect of Peg-IFNα-2b and Imatinib alone or combination on imatinib-resistant gastrointestinal stromal tumors cell lines.
Zhang LY; Huang JS; Pi ZM; Yu MY
Int J Clin Exp Pathol; 2015; 8(9):11340-7. PubMed ID: 26617858
[TBL] [Abstract][Full Text] [Related]
11. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.
Trent JC; Ramdas L; Dupart J; Hunt K; Macapinlac H; Taylor E; Hu L; Salvado A; Abbruzzese JL; Pollock R; Benjamin RS; Zhang W
Cancer; 2006 Oct; 107(8):1898-908. PubMed ID: 16986125
[TBL] [Abstract][Full Text] [Related]
12. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of Metabolic Vulnerability in Imatinib -Resistant Gastrointestinal Stromal Tumor.
Huang WK; Gao J; Chen Z; Shi H; Yuan J; Cui HL; Yeh CN; Bränström R; Larsson C; Li S; Lui WO
Cells; 2020 May; 9(6):. PubMed ID: 32466502
[TBL] [Abstract][Full Text] [Related]
14. The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations.
Floris G; Sciot R; Wozniak A; Van Looy T; Wellens J; Faa G; Normant E; Debiec-Rychter M; Schöffski P
Clin Cancer Res; 2011 Sep; 17(17):5604-14. PubMed ID: 21737509
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro.
Dupart JJ; Trent JC; Lee HY; Hess KR; Godwin AK; Taguchi T; Zhang W
Mol Cancer; 2009 Nov; 8():99. PubMed ID: 19903356
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of stromal-interacting molecule 1-mediated store-operated Ca
Yang Z; Pan L; Liu S; Li F; Lv W; Shu Y; Dong P
Cancer Sci; 2018 Sep; 109(9):2792-2800. PubMed ID: 29957833
[TBL] [Abstract][Full Text] [Related]
17. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
18. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor.
Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X
Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362
[TBL] [Abstract][Full Text] [Related]
19. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation.
Pan F; Den J; Zhang C; Wang H; Cheng J; Wu W; Hong N; Wang Y
PLoS One; 2016; 11(12):e0167720. PubMed ID: 27911930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
